The study aims to collect data on ERBT globally in order to clarify its role in the management of bladder cancer over a 5-year observation period.
Conditions: Bladder Cancer
Eligibility Criteria
Inclusion Criteria
- Adult patients \>=18 years old with informed consent
- Presence of bladder tumour undergoing transurethral ERBT
Exclusion Criteria
- Presence or previous history of upper tract urothelial carcinoma
- Presence of other active malignancy
- Pregnancy
Eligibility criteria are kept as the original English records from ClinicalTrials.gov; actual eligibility is determined by the research team's formal assessment and the informed consent form. Source: ClinicalTrials.gov, updated automatically every two weeks. Last synced: 2026年10月8日.